Cargando…

Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy

SARS-CoV-2 is a global challenge due to its ability to mutate into variants that spread more rapidly than the wild-type virus. Because the molecular biology of this virus has been studied in such great detail, it represents an archetypal paradigm for research into new antiviral drug therapies. The r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ridgway, Harry, Chasapis, Christos T., Kelaidonis, Konstantinos, Ligielli, Irene, Moore, Graham J., Gadanec, Laura Kate, Zulli, Anthony, Apostolopoulos, Vasso, Mavromoustakos, Thomas, Matsoukas, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143829/ https://www.ncbi.nlm.nih.gov/pubmed/35632769 http://dx.doi.org/10.3390/v14051029

Ejemplares similares

Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2
por: Matsoukas, John M., et al.
Publicado: (2022)

Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with Mannan
por: Matsoukas, John M., et al.
Publicado: (2021)

Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
por: Ridgway, Harry, et al.
Publicado: (2023)

Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2
por: Ridgway, Harry, et al.
Publicado: (2022)

The Human Myelin Proteome and Sub-Metalloproteome Interaction Map: Relevance to Myelin-Related Neurological Diseases
por: Chasapis, Christos T., et al.
Publicado: (2022)

From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
por: Matsoukas, John, et al.
Publicado: (2021)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System
por: Moore, Graham J., et al.
Publicado: (2022)

Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
por: Swiderski, Jordan, et al.
Publicado: (2023)

Computational and Enzymatic Studies of Sartans in SARS-CoV-2 Spike RBD-ACE2 Binding: The Role of Tetrazole and Perspectives as Antihypertensive and COVID-19 Therapeutics
por: Kelaidonis, Konstantinos, et al.
Publicado: (2023)

W254 in furin functions as a molecular gate promoting anti-viral drug binding: Elucidation of putative drug tunneling and docking by non-equilibrium molecular dynamics
por: Ridgway, Harry, et al.
Publicado: (2023)

Could DIZE be the answer to COVID-19?
por: Qaradakhi, Tawar, et al.
Publicado: (2020)

Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes
por: Kiouri, Despoina P., et al.
Publicado: (2023)

Glycyrrhizic Acid Inhibits High-Mobility Group Box-1 and Homocysteine-Induced Vascular Dysfunction
por: Gadanec, Laura Kate, et al.
Publicado: (2023)

Combination of Taurine and Black Pepper Extract as a Treatment for Cardiovascular and Coronary Artery Diseases
por: Swiderski, Jordan, et al.
Publicado: (2023)

Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
por: Gadanec, Laura Kate, et al.
Publicado: (2021)

Facile and Efficient Syntheses of a Series of N-Benzyl and N-Biphenylmethyl Substituted Imidazole Derivatives Based on (E)-Urocanic acid, as Angiotensin II AT1 Receptor Blockers
por: Agelis, George, et al.
Publicado: (2013)

The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease
por: Qaradakhi, Tawar, et al.
Publicado: (2020)

Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment
por: Kate Gadanec, Laura, et al.
Publicado: (2021)

Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations
por: McSweeney, Kristen Renee, et al.
Publicado: (2021)

Myelin Peptide–Mannan Conjugate Multiple Sclerosis Vaccines: Conjugation Efficacy and Stability of Vaccine Ingredient
por: Matsoukas, John, et al.
Publicado: (2021)

Advances in Multiple Sclerosis Research–Series I
por: Apostolopoulos, Vasso, et al.
Publicado: (2020)

The Long Road of Immunotherapeutics against Multiple Sclerosis †
por: Apostolopoulos, Vasso, et al.
Publicado: (2020)

Streptococcusthermophilus ST285 Alters Pro-Inflammatory to Anti-Inflammatory Cytokine Secretion against Multiple Sclerosis Peptide in Mice
por: Dargahi, Narges, et al.
Publicado: (2020)

Evaluating the Energetic Driving Force for Cocrystal Formation
por: Taylor, Christopher R., et al.
Publicado: (2017)

The Use of Electrochemical Voltammetric Techniques and High-Pressure Liquid Chromatography to Evaluate Conjugation Efficiency of Multiple Sclerosis Peptide-Carrier Conjugates
por: Deskoulidis, Efstathios, et al.
Publicado: (2020)

Smart therapies against global pandemics: A potential of short peptides
por: Apostolopoulos, Vasso, et al.
Publicado: (2022)

Re-evaluating the driving force behind mutations
por: Leroy, Thibault
Publicado: (2023)

Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP(82–98)) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II
por: Deraos, George, et al.
Publicado: (2018)

Anatomy of the energetic driving force for charge generation in organic solar cells
por: Nakano, Kyohei, et al.
Publicado: (2019)

Detailed Per-residue Energetic Analysis Explains the Driving Force for Microtubule Disassembly
por: Ayoub, Ahmed T., et al.
Publicado: (2015)

Development of Methamphetamine Conjugated Vaccine through Hapten Design: In Vitro and In Vivo Characterization
por: Hossain, Md Kamal, et al.
Publicado: (2023)

Multiple Sclerosis: Immunopathology and Treatment Update
por: Dargahi, Narges, et al.
Publicado: (2017)

Mutation Bias is the Driving Force of Codon Usage in the Gallus gallus genome
por: Rao, Yousheng, et al.
Publicado: (2011)

Mannosylated Linear and Cyclic Single Amino Acid Mutant Peptides Using a Small 10 Amino Acid Linker Constitute Promising Candidates Against Multiple Sclerosis
por: Day, Stephanie, et al.
Publicado: (2015)

Vaccine Delivery Methods into the Future
por: Apostolopoulos, Vasso
Publicado: (2016)

Cancer Vaccines: Research and Applications
por: Apostolopoulos, Vasso
Publicado: (2019)

Mutational Spectrum Drives the Rise of Mutator Bacteria
por: Couce, Alejandro, et al.
Publicado: (2013)

MPV17 Mutations Are Associated With a Quiescent Energetic Metabolic Profile
por: Jacinto, Sandra, et al.
Publicado: (2021)

Kinetic Hairpin Oligonucleotide Blockers for Selective Amplification of Rare Mutations
por: Jia, Yanwei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6t902tr0mn6gvhuerbk8gpt4u5